5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Cardiac Ablation
Cardiac ablation is a medical procedure designed to treat certain heart conditions, particularly those related to irregular heart rhythms or arrhythmias. During the procedure, a catheter is threaded through blood vessels to the heart, where it delivers energy in the form of heat or cold to the targeted areas responsible for the abnormal heart rhythms. This energy creates tiny scars, interrupting the abnormal electrical signals causing the arrhythmia. Cardiac ablation is often recommended when medications prove ineffective in managing irregular heartbeats. This minimally invasive procedure has proven to be a valuable intervention, providing relief for individuals with conditions such as atrial fibrillation. As technology advances, cardiac ablation continues to evolve, offering patients a promising option for restoring normal heart rhythm and improving overall cardiac health.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain